What Happened? Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 3.3% in the afternoon session after ...

For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

He now feels Wave stock rates an outperform (buy, in other words), one full notch up from his previous sector perform (hold).

As of Friday, December 19, Cassava Sciences, Inc.’s SAVA share price has dipped by 17.37%, which has investors questioning if this is right time to buy.

Gilead Sciences said its in-development HIV treatment met the primary endpoint of a recent late-stage clinical trial. The biopharmaceutical company said Monday that the treatment, a once-daily single ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Keeley Wettan will be appointed Executive Vice President, General ...

The developer behind Philadelphia's largest life sciences building says the market needs patience after venture capital ...

Partnerships with giants like Eli Lilly and Thermo Fisher Scientific put biotech in the spotlight again, though founders still struggle to find investments in their hometown.

Struggles at Alexandria Real Estate Equities portend more challenges for the life sciences real estate market.

Duquesne University officials say a new, $68 million health sciences facility will locate clinical services, consolidate ...

UAMS has announced 40 new full-ride scholarships for 2026, with recipients committing to living and working in Arkansas for a ...

The Boise State College of Health Sciences named Nate Williams (‘02 and ‘04), currently an associate professor in the School ...